Calhm2em1Zyu
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Calhm2em1Zyu |
| Name: |
calcium homeostasis modulator family member 2; endonuclease-mediated mutation 1, Zengqiang Yuan |
| MGI ID: |
MGI:8219395 |
| Synonyms: |
Calhm2 V136G |
| Gene: |
Calhm2 Location: Chr19:47120671-47126733 bp, - strand Genetic Position: Chr19, 39.28 cM
|
| Alliance: |
Calhm2em1Zyu page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: CRISPR/Cas9 technology generated a GTG to GGT change resulting in a valine to glycine substitution at amino acid 136 (p.V136G) in exon 2. This variant is associated with Alzheimers disease. In addition, a nonsense mutation (TCC to TCG) at codon 139 was introduced to prevent binding and recutting of the sequence. This is a loss-of-function mutation that attenuates ATP-release function.
(J:368740)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Calhm2 Mutation: |
28 strains or lines available
|
|
| Original: |
J:368740 Liao Y, et al., CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk. Alzheimers Dement. 2023 Oct;19(10):4407-4420 |
| All: |
1 reference(s) |
|